Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis.

Sanli, Oner; Kucukgergin, Canan; Gokpinar, Murat; Tefik, Tzevat; Nane, İsmet; Seckin, Sule

doi:10.1016/j.urolonc.2009.04.011

Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis.

Atıf İçin Kopyala

Sanli O., Kucukgergin C., Gokpinar M., Tefik T., Nane İ., Seckin S.

Urologic oncology, cilt.29, sa.2, ss.183-8, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 2
Basım Tarihi: 2011
Doi Numarası: 10.1016/j.urolonc.2009.04.011
Dergi Adı: Urologic oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
Sayfa Sayıları: ss.183-8
İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: To investigate the relationship between the distribution of endothelial NO synthase (eNOS4a/b) gene polymorphism and clinical features of prostate cancer (PCa).